Rank | Gene Set | Z-score |
---|---|---|
1 | actin-myosin filament sliding (GO:0033275) | 4.61047304 |
2 | muscle filament sliding (GO:0030049) | 4.61047304 |
3 | sarcomere organization (GO:0045214) | 4.31699945 |
4 | * cardiac myofibril assembly (GO:0055003) | 4.22988999 |
5 | cardiac muscle contraction (GO:0060048) | 4.18507368 |
6 | actin-mediated cell contraction (GO:0070252) | 3.85551376 |
7 | regulation of actin filament-based movement (GO:1903115) | 3.71845542 |
8 | * cardiac muscle hypertrophy (GO:0003300) | 3.63640296 |
9 | striated muscle contraction (GO:0006941) | 3.55027453 |
10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.43954326 |
11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.43954326 |
12 | modulation by symbiont of host immune response (GO:0052553) | 3.43954326 |
13 | positive regulation by symbiont of host defense response (GO:0052509) | 3.43954326 |
14 | modulation by symbiont of host defense response (GO:0052031) | 3.43954326 |
15 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.43954326 |
16 | * striated muscle hypertrophy (GO:0014897) | 3.42124754 |
17 | actin filament-based movement (GO:0030048) | 3.38426946 |
18 | regulation of the force of heart contraction (GO:0002026) | 3.37892371 |
19 | cellular response to epinephrine stimulus (GO:0071872) | 3.24080689 |
20 | microglial cell activation (GO:0001774) | 3.13544936 |
21 | * muscle hypertrophy (GO:0014896) | 3.11480916 |
22 | * actomyosin structure organization (GO:0031032) | 3.07021852 |
23 | negative regulation of myotube differentiation (GO:0010832) | 3.02530420 |
24 | macrophage activation involved in immune response (GO:0002281) | 3.01382583 |
25 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.92132128 |
26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.91400652 |
27 | response to epinephrine (GO:0071871) | 2.89213028 |
28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.87144382 |
29 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.85538890 |
30 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.83074683 |
31 | plasma membrane repair (GO:0001778) | 2.82224910 |
32 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.82010181 |
33 | skeletal muscle contraction (GO:0003009) | 2.81626231 |
34 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.80661049 |
35 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.78142856 |
36 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.76463989 |
37 | relaxation of cardiac muscle (GO:0055119) | 2.74806648 |
38 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.74620126 |
39 | negative regulation of cell killing (GO:0031342) | 2.74620126 |
40 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.70516804 |
41 | adult heart development (GO:0007512) | 2.69817531 |
42 | cardiac muscle cell development (GO:0055013) | 2.69769986 |
43 | muscle tissue morphogenesis (GO:0060415) | 2.69173961 |
44 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.68829223 |
45 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.64931162 |
46 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.60708234 |
47 | regulation of cell communication by electrical coupling (GO:0010649) | 2.60391127 |
48 | carnitine shuttle (GO:0006853) | 2.59547232 |
49 | cardiac cell development (GO:0055006) | 2.58728542 |
50 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.53584902 |
51 | I-kappaB phosphorylation (GO:0007252) | 2.52790742 |
52 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.52669514 |
53 | regulation of synapse structural plasticity (GO:0051823) | 2.50536694 |
54 | G-protein coupled receptor internalization (GO:0002031) | 2.49935854 |
55 | response to inactivity (GO:0014854) | 2.47023161 |
56 | cellular response to ethanol (GO:0071361) | 2.44345736 |
57 | response to host immune response (GO:0052572) | 2.43964819 |
58 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.43964819 |
59 | positive regulation of receptor recycling (GO:0001921) | 2.43849143 |
60 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.43827607 |
61 | * cardiac muscle adaptation (GO:0014887) | 2.42377368 |
62 | * cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.42377368 |
63 | * muscle hypertrophy in response to stress (GO:0003299) | 2.42377368 |
64 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.41733507 |
65 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.39944707 |
66 | negative regulation of granulocyte differentiation (GO:0030853) | 2.39149599 |
67 | regulation of cardioblast differentiation (GO:0051890) | 2.36555009 |
68 | muscle contraction (GO:0006936) | 2.36439481 |
69 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.35777360 |
70 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.34789525 |
71 | macrophage activation (GO:0042116) | 2.34697005 |
72 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.33205527 |
73 | response to host (GO:0075136) | 2.33205527 |
74 | response to host defenses (GO:0052200) | 2.33205527 |
75 | synaptic vesicle maturation (GO:0016188) | 2.33040246 |
76 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.31061896 |
77 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.30629445 |
78 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.30242766 |
79 | sodium ion export (GO:0071436) | 2.29883676 |
80 | cell adhesion mediated by integrin (GO:0033627) | 2.29493918 |
81 | clathrin coat assembly (GO:0048268) | 2.28897869 |
82 | detection of molecule of bacterial origin (GO:0032490) | 2.25470279 |
83 | regulation of macrophage cytokine production (GO:0010935) | 2.25335416 |
84 | * striated muscle adaptation (GO:0014888) | 2.25155532 |
85 | positive regulation of myotube differentiation (GO:0010831) | 2.24743173 |
86 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.23792130 |
87 | * muscle system process (GO:0003012) | 2.22583269 |
88 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.21868031 |
89 | nerve growth factor signaling pathway (GO:0038180) | 2.21807421 |
90 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.20331760 |
91 | skeletal muscle adaptation (GO:0043501) | 2.20298229 |
92 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.20137647 |
93 | * regulation of heart contraction (GO:0008016) | 2.19514824 |
94 | detection of calcium ion (GO:0005513) | 2.18708267 |
95 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.18259945 |
96 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.17168620 |
97 | regulation of gamma-delta T cell activation (GO:0046643) | 2.17127177 |
98 | locomotory exploration behavior (GO:0035641) | 2.16508757 |
99 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.16338342 |
100 | activation of protein kinase A activity (GO:0034199) | 2.16253057 |
101 | * regulation of muscle system process (GO:0090257) | 2.16216976 |
102 | substrate-dependent cell migration (GO:0006929) | 2.16117745 |
103 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.13822041 |
104 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.13822041 |
105 | vesicle transport along microtubule (GO:0047496) | 2.13598422 |
106 | fatty acid transmembrane transport (GO:1902001) | 2.13568942 |
107 | venous blood vessel morphogenesis (GO:0048845) | 2.12699106 |
108 | * cardiac chamber formation (GO:0003207) | 2.11656550 |
109 | membrane depolarization during action potential (GO:0086010) | 2.11625785 |
110 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.11451094 |
111 | response to peptidoglycan (GO:0032494) | 2.10846298 |
112 | regulation of heart rate (GO:0002027) | 2.10060916 |
113 | cardiac muscle cell proliferation (GO:0060038) | 2.09152671 |
114 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.08263624 |
115 | regulation of ARF protein signal transduction (GO:0032012) | 2.07879786 |
116 | positive regulation of fibroblast migration (GO:0010763) | 2.06882145 |
117 | regulation of membrane repolarization (GO:0060306) | 2.05683974 |
118 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.02944523 |
119 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.02553589 |
120 | cellular potassium ion homeostasis (GO:0030007) | 2.01949239 |
121 | positive regulation of macrophage cytokine production (GO:0060907) | 1.97988666 |
122 | protein localization to endosome (GO:0036010) | 1.97625163 |
123 | striated muscle atrophy (GO:0014891) | 1.97051953 |
124 | relaxation of muscle (GO:0090075) | 1.97034734 |
125 | positive regulation of cation channel activity (GO:2001259) | 1.94661284 |
126 | regulation of Rap GTPase activity (GO:0032317) | 1.93648540 |
127 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 1.92294804 |
128 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 1.92294804 |
129 | regulation of translation, ncRNA-mediated (GO:0045974) | 1.92294804 |
130 | potassium ion import (GO:0010107) | 1.91918590 |
131 | regulation of skeletal muscle contraction (GO:0014819) | 1.91773438 |
132 | regulation of striated muscle contraction (GO:0006942) | 1.91473744 |
133 | positive regulation of myoblast differentiation (GO:0045663) | 1.91011700 |
134 | synaptic vesicle endocytosis (GO:0048488) | 1.90784758 |
135 | glutamate receptor signaling pathway (GO:0007215) | 1.90411488 |
136 | * myofibril assembly (GO:0030239) | 1.89034118 |
137 | regulation of relaxation of muscle (GO:1901077) | 1.88565471 |
138 | cell communication involved in cardiac conduction (GO:0086065) | 1.88365978 |
139 | phosphatidylinositol dephosphorylation (GO:0046856) | 1.87902017 |
140 | response to muramyl dipeptide (GO:0032495) | 1.87770884 |
141 | vocalization behavior (GO:0071625) | 1.87669725 |
142 | cell communication by electrical coupling (GO:0010644) | 1.87032182 |
143 | positive regulation of Rap GTPase activity (GO:0032854) | 1.86369773 |
144 | neutrophil mediated immunity (GO:0002446) | 1.86367761 |
145 | myeloid cell activation involved in immune response (GO:0002275) | 1.85835275 |
146 | cytoplasmic mRNA processing body assembly (GO:0033962) | 1.85790490 |
147 | muscle atrophy (GO:0014889) | 1.85281587 |
148 | regulation of cation channel activity (GO:2001257) | 1.84050502 |
149 | * regulation of glutamate receptor signaling pathway (GO:1900449) | 1.84026080 |
150 | L-amino acid import (GO:0043092) | 1.83896901 |
151 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 1.83543017 |
152 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 1.83455081 |
153 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 1.82704822 |
154 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 1.82363952 |
155 | regulation of p38MAPK cascade (GO:1900744) | 1.82065635 |
156 | regulation of cardiac muscle contraction (GO:0055117) | 1.82053654 |
157 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 1.82031392 |
158 | * regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 1.81502051 |
159 | axon extension involved in axon guidance (GO:0048846) | 1.81147150 |
160 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 1.81147150 |
161 | * cardiac conduction (GO:0061337) | 1.81032672 |
162 | regulation of ARF GTPase activity (GO:0032312) | 1.80899651 |
Rank | Gene Set | Z-score |
---|---|---|
1 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.61410669 |
2 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.33104148 |
3 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.26946275 |
4 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.12430791 |
5 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.03969957 |
6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.86896082 |
7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.84924267 |
8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.84251286 |
9 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.81645431 |
10 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.80692021 |
11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.80362935 |
12 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.78441538 |
13 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.78246027 |
14 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.78246027 |
15 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.77128465 |
16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.75335924 |
17 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.74874054 |
18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.68640385 |
19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.64410511 |
20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.64347012 |
21 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.64177635 |
22 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.63484917 |
23 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.61892394 |
24 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.61892394 |
25 | TP53_16413492_ChIP-PET_HCT116_Human | 1.55539767 |
26 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.55458312 |
27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.54538856 |
28 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.54278764 |
29 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.53248305 |
30 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.52737919 |
31 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.50934075 |
32 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.48497653 |
33 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46394104 |
34 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.42415393 |
35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.41646977 |
36 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.41621130 |
37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.40472689 |
38 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.39879793 |
39 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.38222378 |
40 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.36753352 |
41 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.35300501 |
42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.34480205 |
43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34445238 |
44 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34224005 |
45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31679701 |
46 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.31602173 |
47 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.30182346 |
48 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.29925296 |
49 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.29137971 |
50 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.28726686 |
51 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.27938643 |
52 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.27897277 |
53 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.25921916 |
54 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.24515553 |
55 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.23708540 |
56 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.23140819 |
57 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.22162978 |
58 | P300_19829295_ChIP-Seq_ESCs_Human | 1.21281366 |
59 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20129375 |
60 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.19469736 |
61 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19357216 |
62 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.18295335 |
63 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.18274617 |
64 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.18169536 |
65 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.17249728 |
66 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.16971072 |
67 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.16724238 |
68 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.16385812 |
69 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.15444951 |
70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15078990 |
71 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.14693904 |
72 | CJUN_26792858_Chip-Seq_BT549_Human | 1.14157434 |
73 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.13769301 |
74 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.13769301 |
75 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.13625203 |
76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12996399 |
77 | RXR_22108803_ChIP-Seq_LS180_Human | 1.12887583 |
78 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.12706217 |
79 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12321733 |
80 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09690009 |
81 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.09653083 |
82 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.08944128 |
83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08603536 |
84 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08175955 |
85 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.08153338 |
86 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.07386866 |
87 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07264997 |
88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07260269 |
89 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07233478 |
90 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07168193 |
91 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.07009300 |
92 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.06317567 |
93 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06163222 |
94 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06135677 |
95 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05271879 |
96 | AR_25329375_ChIP-Seq_VCAP_Human | 1.05253301 |
97 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05138817 |
98 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04886302 |
99 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.04531440 |
100 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.03961795 |
101 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.03027144 |
102 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01714229 |
103 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.01636285 |
104 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.00930677 |
105 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00194187 |
106 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.00163573 |
107 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99186942 |
108 | TCF4_23295773_ChIP-Seq_U87_Human | 0.98968365 |
109 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.98473992 |
110 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98360514 |
111 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98193547 |
112 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.96688761 |
113 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96639605 |
114 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.96455663 |
115 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.96001976 |
116 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95474839 |
117 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95394926 |
118 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95223617 |
119 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.95095716 |
120 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.94839451 |
121 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94500794 |
122 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.94395549 |
123 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.93590992 |
124 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.93462071 |
125 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.92625551 |
126 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.92180674 |
127 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.91742561 |
128 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91717609 |
129 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91460663 |
130 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.91324087 |
131 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.91289388 |
132 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90905284 |
133 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90780132 |
134 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90780132 |
135 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90287796 |
136 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.90198198 |
137 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89625325 |
138 | GATA1_22025678_ChIP-Seq_K562_Human | 0.89608461 |
139 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89018623 |
140 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88816358 |
141 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.86766819 |
142 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.86435940 |
143 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.84730764 |
144 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83798859 |
145 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83527172 |
146 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.81881175 |
147 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.81271248 |
148 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.81271248 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000569_abnormal_digit_pigmentation | 5.77223197 |
2 | MP0004859_abnormal_synaptic_plasticity | 3.25277080 |
3 | MP0004510_myositis | 2.89494998 |
4 | MP0000751_myopathy | 2.49035053 |
5 | MP0003828_pulmonary_edema | 2.30758135 |
6 | MP0004084_abnormal_cardiac_muscle | 2.07881123 |
7 | MP0004484_altered_response_of | 2.03342871 |
8 | MP0003172_abnormal_lysosome_physiology | 1.98879581 |
9 | MP0005167_abnormal_blood-brain_barrier | 1.87817263 |
10 | MP0004270_analgesia | 1.77328570 |
11 | MP0003045_fibrosis | 1.77266967 |
12 | MP0003635_abnormal_synaptic_transmissio | 1.75390292 |
13 | MP0004215_abnormal_myocardial_fiber | 1.74700801 |
14 | MP0009780_abnormal_chondrocyte_physiolo | 1.67509589 |
15 | MP0005058_abnormal_lysosome_morphology | 1.67328002 |
16 | MP0000749_muscle_degeneration | 1.67318736 |
17 | MP0009046_muscle_twitch | 1.66686365 |
18 | MP0004130_abnormal_muscle_cell | 1.64892881 |
19 | MP0004036_abnormal_muscle_relaxation | 1.63087256 |
20 | MP0004145_abnormal_muscle_electrophysio | 1.61758999 |
21 | MP0002009_preneoplasia | 1.60305130 |
22 | MP0003300_gastrointestinal_ulcer | 1.59959235 |
23 | MP0003724_increased_susceptibility_to | 1.57640641 |
24 | MP0002837_dystrophic_cardiac_calcinosis | 1.55217894 |
25 | MP0003191_abnormal_cellular_cholesterol | 1.52350242 |
26 | MP0002972_abnormal_cardiac_muscle | 1.52142352 |
27 | MP0003303_peritoneal_inflammation | 1.51100589 |
28 | MP0002269_muscular_atrophy | 1.50169973 |
29 | MP0001879_abnormal_lymphatic_vessel | 1.48264184 |
30 | MP0005275_abnormal_skin_tensile | 1.47436681 |
31 | MP0000015_abnormal_ear_pigmentation | 1.47366974 |
32 | MP0005409_darkened_coat_color | 1.44395969 |
33 | MP0005174_abnormal_tail_pigmentation | 1.42656225 |
34 | MP0009745_abnormal_behavioral_response | 1.42456574 |
35 | MP0005451_abnormal_body_composition | 1.41178097 |
36 | MP0003183_abnormal_peptide_metabolism | 1.40079097 |
37 | MP0003950_abnormal_plasma_membrane | 1.37356493 |
38 | MP0000685_abnormal_immune_system | 1.37213592 |
39 | MP0004087_abnormal_muscle_fiber | 1.34904903 |
40 | MP0002064_seizures | 1.34221425 |
41 | MP0003787_abnormal_imprinting | 1.33636194 |
42 | MP0002063_abnormal_learning/memory/cond | 1.32668604 |
43 | MP0003279_aneurysm | 1.30782812 |
44 | MP0002998_abnormal_bone_remodeling | 1.30325644 |
45 | MP0003091_abnormal_cell_migration | 1.30272025 |
46 | MP0001790_abnormal_immune_system | 1.28965377 |
47 | MP0005387_immune_system_phenotype | 1.28965377 |
48 | MP0005620_abnormal_muscle_contractility | 1.27945225 |
49 | MP0003705_abnormal_hypodermis_morpholog | 1.27308549 |
50 | MP0003880_abnormal_central_pattern | 1.25780558 |
51 | MP0002971_abnormal_brown_adipose | 1.23593524 |
52 | MP0005165_increased_susceptibility_to | 1.22726587 |
53 | MP0002127_abnormal_cardiovascular_syste | 1.22453263 |
54 | MP0000767_abnormal_smooth_muscle | 1.22041316 |
55 | MP0003690_abnormal_glial_cell | 1.21582056 |
56 | MP0002877_abnormal_melanocyte_morpholog | 1.19588038 |
57 | MP0002106_abnormal_muscle_physiology | 1.19170549 |
58 | MP0005623_abnormal_meninges_morphology | 1.18825296 |
59 | MP0009278_abnormal_bone_marrow | 1.16098734 |
60 | MP0005670_abnormal_white_adipose | 1.15249473 |
61 | MP0010630_abnormal_cardiac_muscle | 1.15029971 |
62 | MP0003566_abnormal_cell_adhesion | 1.14974921 |
63 | MP0002419_abnormal_innate_immunity | 1.14440977 |
64 | MP0002254_reproductive_system_inflammat | 1.13728122 |
65 | MP0008775_abnormal_heart_ventricle | 1.12651165 |
66 | MP0005666_abnormal_adipose_tissue | 1.12615563 |
67 | MP0001958_emphysema | 1.11680993 |
68 | MP0001486_abnormal_startle_reflex | 1.10686187 |
69 | MP0004233_abnormal_muscle_weight | 1.09375025 |
70 | MP0010368_abnormal_lymphatic_system | 1.06966201 |
71 | MP0001851_eye_inflammation | 1.06621125 |
72 | MP0000733_abnormal_muscle_development | 1.06601516 |
73 | MP0003075_altered_response_to | 1.05269048 |
74 | MP0005330_cardiomyopathy | 1.03723872 |
75 | MP0005369_muscle_phenotype | 1.03160542 |
76 | MP0002572_abnormal_emotion/affect_behav | 1.03115107 |
77 | MP0003633_abnormal_nervous_system | 1.02957719 |
78 | MP0005375_adipose_tissue_phenotype | 1.02549115 |
79 | MP0002166_altered_tumor_susceptibility | 1.00519937 |
80 | MP0005000_abnormal_immune_tolerance | 1.00470658 |
81 | MP0001835_abnormal_antigen_presentation | 1.00415110 |
82 | MP0003137_abnormal_impulse_conducting | 0.99648394 |
83 | MP0001299_abnormal_eye_distance/ | 0.99134466 |
84 | MP0003763_abnormal_thymus_physiology | 0.97785059 |
85 | * MP0004085_abnormal_heartbeat | 0.96545304 |
86 | MP0001968_abnormal_touch/_nociception | 0.96395769 |
87 | MP0000750_abnormal_muscle_regeneration | 0.95050405 |
88 | MP0001661_extended_life_span | 0.93802028 |
89 | MP0000747_muscle_weakness | 0.93390978 |
90 | MP0002090_abnormal_vision | 0.93158584 |
91 | MP0001800_abnormal_humoral_immune | 0.92632071 |
92 | MP0001501_abnormal_sleep_pattern | 0.92554331 |
93 | MP0002909_abnormal_adrenal_gland | 0.92379750 |
94 | MP0005171_absent_coat_pigmentation | 0.91996799 |
95 | MP0000604_amyloidosis | 0.91764407 |
96 | MP0002108_abnormal_muscle_morphology | 0.90527377 |
97 | MP0001533_abnormal_skeleton_physiology | 0.90233902 |
98 | MP0000759_abnormal_skeletal_muscle | 0.90215320 |
99 | MP0000383_abnormal_hair_follicle | 0.89430275 |
100 | MP0006082_CNS_inflammation | 0.88899310 |
101 | MP0001440_abnormal_grooming_behavior | 0.88792820 |
102 | MP0002067_abnormal_sensory_capabilities | 0.88784314 |
103 | MP0000343_altered_response_to | 0.88594477 |
104 | MP0002735_abnormal_chemical_nociception | 0.88064335 |
105 | MP0005464_abnormal_platelet_physiology | 0.87973991 |
106 | MP0001544_abnormal_cardiovascular_syste | 0.87797772 |
107 | MP0005385_cardiovascular_system_phenoty | 0.87797772 |
108 | MP0008438_abnormal_cutaneous_collagen | 0.87574507 |
109 | MP0008569_lethality_at_weaning | 0.86907832 |
110 | MP0008004_abnormal_stomach_pH | 0.86851916 |
111 | MP0003646_muscle_fatigue | 0.85148053 |
112 | MP0002734_abnormal_mechanical_nocicepti | 0.84862066 |
113 | MP0010678_abnormal_skin_adnexa | 0.82828594 |
114 | MP0002452_abnormal_antigen_presenting | 0.82651004 |
115 | MP0009785_altered_susceptibility_to | 0.81266040 |
116 | MP0003436_decreased_susceptibility_to | 0.80596308 |
117 | MP0003221_abnormal_cardiomyocyte_apopto | 0.80099166 |
118 | MP0003329_amyloid_beta_deposits | 0.78677280 |
119 | MP0006138_congestive_heart_failure | 0.78048417 |
120 | MP0001188_hyperpigmentation | 0.77984651 |
121 | MP0002723_abnormal_immune_serum | 0.77525245 |
122 | MP0000003_abnormal_adipose_tissue | 0.77451034 |
123 | MP0004947_skin_inflammation | 0.77450891 |
124 | MP0000920_abnormal_myelination | 0.77264315 |
125 | MP0004272_abnormal_basement_membrane | 0.76470124 |
126 | MP0009115_abnormal_fat_cell | 0.75971543 |
127 | MP0002928_abnormal_bile_duct | 0.75906994 |
128 | MP0008961_abnormal_basal_metabolism | 0.75783117 |
129 | MP0000249_abnormal_blood_vessel | 0.75651093 |
130 | MP0005503_abnormal_tendon_morphology | 0.75624790 |
131 | MP0005166_decreased_susceptibility_to | 0.74787946 |
132 | MP0002133_abnormal_respiratory_system | 0.74554035 |
133 | MP0005388_respiratory_system_phenotype | 0.74554035 |
134 | MP0002006_tumorigenesis | 0.73772012 |
135 | MP0002896_abnormal_bone_mineralization | 0.72965292 |
136 | MP0005025_abnormal_response_to | 0.72468384 |
137 | MP0002332_abnormal_exercise_endurance | 0.72368561 |
138 | MP0000013_abnormal_adipose_tissue | 0.72160519 |
139 | MP0002148_abnormal_hypersensitivity_rea | 0.72090712 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nemaline bodies (HP:0003798) | 4.10675740 |
2 | Distal lower limb amyotrophy (HP:0008944) | 3.49073158 |
3 | Lower limb amyotrophy (HP:0007210) | 3.38552132 |
4 | Hypoplastic ischia (HP:0003175) | 3.37952996 |
5 | Heart block (HP:0012722) | 3.19874600 |
6 | Sudden death (HP:0001699) | 3.17746191 |
7 | Abnormal atrioventricular conduction (HP:0005150) | 3.09500160 |
8 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.04669570 |
9 | Ventricular arrhythmia (HP:0004308) | 2.99404701 |
10 | Papilledema (HP:0001085) | 2.99231413 |
11 | Abnormality of the ischium (HP:0003174) | 2.99159064 |
12 | Lipoatrophy (HP:0100578) | 2.99022779 |
13 | Focal motor seizures (HP:0011153) | 2.97991861 |
14 | Right ventricular cardiomyopathy (HP:0011663) | 2.95607773 |
15 | Thick nail (HP:0001805) | 2.88380993 |
16 | Arterial tortuosity (HP:0005116) | 2.86709692 |
17 | Febrile seizures (HP:0002373) | 2.84372359 |
18 | Spontaneous hematomas (HP:0007420) | 2.79049464 |
19 | Facial diplegia (HP:0001349) | 2.77313055 |
20 | Atrioventricular block (HP:0001678) | 2.73869578 |
21 | Hyporeflexia of lower limbs (HP:0002600) | 2.72597983 |
22 | Hematochezia (HP:0002573) | 2.72403140 |
23 | Absent frontal sinuses (HP:0002688) | 2.71671506 |
24 | Neck muscle weakness (HP:0000467) | 2.70715404 |
25 | Distal lower limb muscle weakness (HP:0009053) | 2.68054727 |
26 | Recurrent abscess formation (HP:0002722) | 2.64621310 |
27 | Atrial fibrillation (HP:0005110) | 2.64050840 |
28 | Increased cerebral lipofuscin (HP:0011813) | 2.61344316 |
29 | Abnormality of the calf musculature (HP:0001430) | 2.60136745 |
30 | Cerebral aneurysm (HP:0004944) | 2.57402782 |
31 | Dilated cardiomyopathy (HP:0001644) | 2.57164919 |
32 | Round ear (HP:0100830) | 2.54270401 |
33 | Calf muscle hypertrophy (HP:0008981) | 2.53548042 |
34 | Vascular tortuosity (HP:0004948) | 2.51598222 |
35 | EMG: neuropathic changes (HP:0003445) | 2.51494421 |
36 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.50333508 |
37 | Primary atrial arrhythmia (HP:0001692) | 2.46403407 |
38 | EMG: myopathic abnormalities (HP:0003458) | 2.45485670 |
39 | Exercise-induced myalgia (HP:0003738) | 2.41011916 |
40 | Syncope (HP:0001279) | 2.40569412 |
41 | Focal seizures (HP:0007359) | 2.40505670 |
42 | Muscle fiber splitting (HP:0003555) | 2.38849047 |
43 | Ventricular fibrillation (HP:0001663) | 2.37780351 |
44 | Recurrent bacterial skin infections (HP:0005406) | 2.37664350 |
45 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.33695106 |
46 | Difficulty running (HP:0009046) | 2.30800915 |
47 | Prolonged QT interval (HP:0001657) | 2.29314101 |
48 | Spondylolisthesis (HP:0003302) | 2.25153125 |
49 | Type 1 muscle fiber predominance (HP:0003803) | 2.23276084 |
50 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.23100150 |
51 | Ulnar deviation of the wrist (HP:0003049) | 2.21788631 |
52 | Rhabdomyolysis (HP:0003201) | 2.21184354 |
53 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.19069725 |
54 | Distal arthrogryposis (HP:0005684) | 2.18883211 |
55 | Supraventricular tachycardia (HP:0004755) | 2.17676437 |
56 | Myoglobinuria (HP:0002913) | 2.17213177 |
57 | Mutism (HP:0002300) | 2.16412504 |
58 | Inappropriate behavior (HP:0000719) | 2.16240910 |
59 | Supraventricular arrhythmia (HP:0005115) | 2.15481017 |
60 | Overgrowth (HP:0001548) | 2.13475572 |
61 | Exotropia (HP:0000577) | 2.12878128 |
62 | Fetal akinesia sequence (HP:0001989) | 2.11354536 |
63 | Prostate neoplasm (HP:0100787) | 2.10421301 |
64 | Aortic aneurysm (HP:0004942) | 2.10205159 |
65 | Abnormality of the frontal sinuses (HP:0002687) | 2.09374188 |
66 | Urethral obstruction (HP:0000796) | 2.08386585 |
67 | Genetic anticipation (HP:0003743) | 2.08005006 |
68 | Abnormality of the foot musculature (HP:0001436) | 2.05072056 |
69 | Progressive cerebellar ataxia (HP:0002073) | 2.04447934 |
70 | Frequent falls (HP:0002359) | 2.03104805 |
71 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.02139438 |
72 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.01355323 |
73 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.01355323 |
74 | Abnormality of glycolipid metabolism (HP:0010969) | 2.01355323 |
75 | Increased connective tissue (HP:0009025) | 2.00690033 |
76 | Action tremor (HP:0002345) | 1.99690057 |
77 | Foot dorsiflexor weakness (HP:0009027) | 1.99516923 |
78 | Sudden cardiac death (HP:0001645) | 1.98025448 |
79 | Abnormality of the endocardium (HP:0004306) | 1.96661537 |
80 | Hip contracture (HP:0003273) | 1.96397368 |
81 | Obstructive sleep apnea (HP:0002870) | 1.96186080 |
82 | Submucous cleft hard palate (HP:0000176) | 1.95561138 |
83 | Epiphyseal dysplasia (HP:0002656) | 1.94968189 |
84 | Axonal loss (HP:0003447) | 1.93722602 |
85 | Limited hip movement (HP:0008800) | 1.92541818 |
86 | Scapular winging (HP:0003691) | 1.92166249 |
87 | Disinhibition (HP:0000734) | 1.91249521 |
88 | Dysostosis multiplex (HP:0000943) | 1.89681456 |
89 | Asymmetric septal hypertrophy (HP:0001670) | 1.88833110 |
90 | Aneurysm (HP:0002617) | 1.88402468 |
91 | Eczematoid dermatitis (HP:0000976) | 1.88299424 |
92 | Excessive salivation (HP:0003781) | 1.86732001 |
93 | Drooling (HP:0002307) | 1.86732001 |
94 | Systemic lupus erythematosus (HP:0002725) | 1.86496381 |
95 | Pulmonary artery stenosis (HP:0004415) | 1.84797586 |
96 | Progressive inability to walk (HP:0002505) | 1.82131543 |
97 | Subaortic stenosis (HP:0001682) | 1.81764120 |
98 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.81764120 |
99 | Areflexia of lower limbs (HP:0002522) | 1.81381824 |
100 | Supranuclear gaze palsy (HP:0000605) | 1.81262406 |
101 | Palpitations (HP:0001962) | 1.81210887 |
102 | Widely spaced teeth (HP:0000687) | 1.80053381 |
103 | Absent speech (HP:0001344) | 1.79790118 |
104 | Gaze-evoked nystagmus (HP:0000640) | 1.78875524 |
105 | Steppage gait (HP:0003376) | 1.78770296 |
106 | Epileptic encephalopathy (HP:0200134) | 1.78727570 |
107 | Aortic dissection (HP:0002647) | 1.77555355 |
108 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.77258958 |
109 | Hyperkalemia (HP:0002153) | 1.77001754 |
110 | Mask-like facies (HP:0000298) | 1.76285344 |
111 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.76126502 |
112 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.76091748 |
113 | Abnormal EKG (HP:0003115) | 1.74747463 |
114 | Broad metatarsal (HP:0001783) | 1.74645354 |
115 | Mitral valve prolapse (HP:0001634) | 1.74640027 |
116 | Generalized muscle weakness (HP:0003324) | 1.73879468 |
117 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.73113116 |
118 | Osteolytic defects of the hand bones (HP:0009699) | 1.73113116 |
119 | Dysmetric saccades (HP:0000641) | 1.72846283 |
120 | Exercise-induced muscle cramps (HP:0003710) | 1.72738292 |
121 | Gingivitis (HP:0000230) | 1.71520605 |
122 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.68612759 |
123 | Gowers sign (HP:0003391) | 1.68376454 |
124 | Macroorchidism (HP:0000053) | 1.68175516 |
125 | Muscle fiber inclusion bodies (HP:0100299) | 1.68156950 |
126 | Visual hallucinations (HP:0002367) | 1.67904161 |
127 | Atonic seizures (HP:0010819) | 1.67318841 |
128 | Broad-based gait (HP:0002136) | 1.67242857 |
129 | Increased variability in muscle fiber diameter (HP:0003557) | 1.67161693 |
130 | Metaphyseal dysplasia (HP:0100255) | 1.66195904 |
131 | Narrow palate (HP:0000189) | 1.66187188 |
132 | Bundle branch block (HP:0011710) | 1.64805195 |
133 | Persistence of primary teeth (HP:0006335) | 1.63969356 |
134 | Striae distensae (HP:0001065) | 1.62958215 |
135 | Onion bulb formation (HP:0003383) | 1.62235397 |
136 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.61572440 |
137 | Abnormality of the right ventricle (HP:0001707) | 1.60674700 |
138 | Generalized tonic-clonic seizures (HP:0002069) | 1.60578459 |
139 | Ventricular tachycardia (HP:0004756) | 1.60572417 |
140 | Abnormality of the nasal septum (HP:0000419) | 1.60474092 |
141 | Rimmed vacuoles (HP:0003805) | 1.60235176 |
142 | Lower limb asymmetry (HP:0100559) | 1.60083838 |
143 | Esophageal varix (HP:0002040) | 1.59938919 |
144 | Rapidly progressive (HP:0003678) | 1.59897186 |
145 | Gastrointestinal stroma tumor (HP:0100723) | 1.59745804 |
146 | Dilatation of the ascending aorta (HP:0005111) | 1.59573281 |
147 | Bulbar palsy (HP:0001283) | 1.53969199 |
148 | Mucopolysacchariduria (HP:0008155) | 1.53335730 |
149 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.53335730 |
150 | Fatigue (HP:0012378) | 1.52516081 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 3.28141839 |
2 | TGFBR2 | 2.92654690 |
3 | CAMK1G | 2.30213315 |
4 | CAMK1D | 2.20800940 |
5 | DMPK | 2.08569775 |
6 | NEK9 | 2.06246363 |
7 | EPHA4 | 1.98629168 |
8 | MYLK | 1.93394698 |
9 | BLK | 1.91190690 |
10 | PKN2 | 1.87803404 |
11 | GRK7 | 1.85190912 |
12 | SIK2 | 1.83498857 |
13 | TTN | 1.83208770 |
14 | RIPK1 | 1.78327505 |
15 | NTRK3 | 1.74971638 |
16 | INSRR | 1.65881512 |
17 | MAP3K13 | 1.60863619 |
18 | DAPK2 | 1.55305751 |
19 | MAP2K3 | 1.52461639 |
20 | CDC42BPA | 1.47587795 |
21 | CAMKK2 | 1.44922061 |
22 | MAP3K9 | 1.44017542 |
23 | MAP3K14 | 1.43887374 |
24 | ERN1 | 1.34049456 |
25 | JAK1 | 1.32217839 |
26 | PTK2B | 1.29479644 |
27 | SGK2 | 1.26424686 |
28 | FES | 1.23491018 |
29 | SGK3 | 1.22948337 |
30 | CAMKK1 | 1.22774908 |
31 | SYK | 1.11758270 |
32 | MAP3K4 | 1.11177228 |
33 | PLK2 | 1.09870682 |
34 | PDGFRA | 1.09682449 |
35 | PIK3CA | 1.08439972 |
36 | WNK1 | 1.06433724 |
37 | PRPF4B | 1.04724462 |
38 | PHKG1 | 1.02198730 |
39 | PHKG2 | 1.02198730 |
40 | OBSCN | 1.02111251 |
41 | STK24 | 1.00935506 |
42 | FGFR3 | 0.99909595 |
43 | MAP3K10 | 0.98453976 |
44 | HCK | 0.97974190 |
45 | FGFR2 | 0.97042379 |
46 | CAMK4 | 0.96627018 |
47 | ZAP70 | 0.96261060 |
48 | SGK1 | 0.95419424 |
49 | KIT | 0.94651875 |
50 | MOS | 0.94407260 |
51 | * MAPK7 | 0.92694876 |
52 | JAK3 | 0.92231200 |
53 | MAP3K7 | 0.91516340 |
54 | CSF1R | 0.90420414 |
55 | CSK | 0.88594181 |
56 | PDGFRB | 0.87111705 |
57 | TIE1 | 0.86764143 |
58 | NLK | 0.85292857 |
59 | BMPR2 | 0.85282121 |
60 | CAMK1 | 0.85095761 |
61 | CDK12 | 0.84976781 |
62 | PRKCH | 0.84333511 |
63 | TRPM7 | 0.81672404 |
64 | PDK1 | 0.81560212 |
65 | JAK2 | 0.81042066 |
66 | MAP3K6 | 0.79879607 |
67 | EEF2K | 0.79550148 |
68 | AKT3 | 0.75959570 |
69 | TYK2 | 0.75757379 |
70 | MAP3K2 | 0.75668114 |
71 | PAK6 | 0.74827411 |
72 | SGK223 | 0.73309977 |
73 | SGK494 | 0.73309977 |
74 | PDPK1 | 0.73135834 |
75 | MAP3K1 | 0.72924529 |
76 | TRIB3 | 0.71509951 |
77 | PTK6 | 0.70657454 |
78 | PRKCE | 0.70457643 |
79 | MUSK | 0.70158153 |
80 | NUAK1 | 0.70017792 |
81 | FRK | 0.69525130 |
82 | STK38 | 0.69246953 |
83 | PRKAA2 | 0.68797433 |
84 | TAOK3 | 0.67738423 |
85 | PDK2 | 0.66694296 |
86 | STK11 | 0.65843204 |
87 | ITK | 0.65837947 |
88 | * CDK5 | 0.65054573 |
89 | PRKD1 | 0.64915412 |
90 | MAP2K4 | 0.64667544 |
91 | RET | 0.63275596 |
92 | ERBB3 | 0.63051935 |
93 | MAP3K3 | 0.62961663 |
94 | FER | 0.62783539 |
95 | GRK5 | 0.62592340 |
96 | FLT3 | 0.62468886 |
97 | PKN1 | 0.62088502 |
98 | FGR | 0.61871848 |
99 | KSR2 | 0.61377380 |
100 | MAP2K7 | 0.60646482 |
101 | SIK3 | 0.60562355 |
102 | MINK1 | 0.60144887 |
103 | TBK1 | 0.60078564 |
104 | MAPK4 | 0.59918568 |
105 | MAP3K5 | 0.59324131 |
106 | MAPK15 | 0.57457341 |
107 | FGFR4 | 0.56771121 |
108 | LMTK2 | 0.56380363 |
109 | FYN | 0.56104090 |
110 | EPHB1 | 0.54948247 |
111 | LATS2 | 0.54794709 |
112 | PAK3 | 0.54492789 |
113 | IRAK3 | 0.54272427 |
114 | CAMK2A | 0.54212399 |
115 | PRKCQ | 0.54125661 |
116 | NTRK1 | 0.53974317 |
117 | STK38L | 0.53904141 |
118 | NTRK2 | 0.53292148 |
119 | MARK2 | 0.53063323 |
120 | IKBKE | 0.52977735 |
121 | DDR2 | 0.51539173 |
122 | PIK3CG | 0.50873572 |
123 | MARK3 | 0.50655164 |
124 | BTK | 0.49244904 |
125 | * MAPK12 | 0.49219286 |
126 | MAPKAPK3 | 0.49092691 |
127 | MAP4K1 | 0.48989288 |
128 | EGFR | 0.48957048 |
129 | NEK6 | 0.48338589 |
130 | MARK1 | 0.47782667 |
131 | PRKAA1 | 0.46779766 |
132 | TXK | 0.46770408 |
133 | CDK6 | 0.46311174 |
134 | EPHA3 | 0.44879071 |
135 | ICK | 0.44792868 |
136 | HIPK2 | 0.43538451 |
137 | RPS6KA2 | 0.42518166 |
138 | ROCK1 | 0.42444112 |
139 | KSR1 | 0.41923112 |
140 | MAPK11 | 0.40508298 |
141 | MAP2K1 | 0.39008104 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Circadian rhythm_Homo sapiens_hsa04710 | 1.72644071 |
2 | Olfactory transduction_Homo sapiens_hsa04740 | 1.72183629 |
3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.63398682 |
4 | Circadian entrainment_Homo sapiens_hsa04713 | 1.48003710 |
5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.46877434 |
6 | Renin secretion_Homo sapiens_hsa04924 | 1.46100324 |
7 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.42133682 |
8 | Long-term potentiation_Homo sapiens_hsa04720 | 1.39843506 |
9 | Morphine addiction_Homo sapiens_hsa05032 | 1.38712997 |
10 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.37141038 |
11 | Nicotine addiction_Homo sapiens_hsa05033 | 1.33816948 |
12 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.32565201 |
13 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.30428157 |
14 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.30298574 |
15 | Salivary secretion_Homo sapiens_hsa04970 | 1.29769587 |
16 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.29618477 |
17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.28774763 |
18 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.24110992 |
19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.22040781 |
20 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.22037211 |
21 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.21184098 |
22 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.21125952 |
23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.20089301 |
24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.16954205 |
25 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.15706422 |
26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.14623933 |
27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.14122545 |
28 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.13240179 |
29 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.12186203 |
30 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.10198875 |
31 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.10091126 |
32 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09120850 |
33 | GABAergic synapse_Homo sapiens_hsa04727 | 1.09043989 |
34 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.08561593 |
35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04541342 |
36 | Leishmaniasis_Homo sapiens_hsa05140 | 1.04228996 |
37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04167821 |
38 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.02105036 |
39 | Glioma_Homo sapiens_hsa05214 | 1.00979919 |
40 | Tuberculosis_Homo sapiens_hsa05152 | 1.00805363 |
41 | Insulin secretion_Homo sapiens_hsa04911 | 0.99756601 |
42 | Focal adhesion_Homo sapiens_hsa04510 | 0.99541538 |
43 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.98305731 |
44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.97802864 |
45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.96312385 |
46 | Long-term depression_Homo sapiens_hsa04730 | 0.95043586 |
47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.94942916 |
48 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94490599 |
49 | Platelet activation_Homo sapiens_hsa04611 | 0.94410616 |
50 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.93922785 |
51 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.93554756 |
52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93156896 |
53 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.92174816 |
54 | Taste transduction_Homo sapiens_hsa04742 | 0.91995975 |
55 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.91931325 |
56 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.90806506 |
57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89371330 |
58 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88435241 |
59 | Amoebiasis_Homo sapiens_hsa05146 | 0.87374988 |
60 | Axon guidance_Homo sapiens_hsa04360 | 0.87166890 |
61 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87092986 |
62 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85816420 |
63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85735520 |
64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85169042 |
65 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.84803973 |
66 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.84428035 |
67 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.84399715 |
68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.84110349 |
69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83997154 |
70 | Lysosome_Homo sapiens_hsa04142 | 0.83625893 |
71 | Pertussis_Homo sapiens_hsa05133 | 0.83397473 |
72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83244340 |
73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83115030 |
74 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.82765744 |
75 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.82578448 |
76 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.81741204 |
77 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.81482054 |
78 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.81099280 |
79 | Malaria_Homo sapiens_hsa05144 | 0.80961906 |
80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.80720889 |
81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.79557741 |
82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79359555 |
83 | Cocaine addiction_Homo sapiens_hsa05030 | 0.78775158 |
84 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.78625698 |
85 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.78192416 |
86 | Allograft rejection_Homo sapiens_hsa05330 | 0.77727389 |
87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77679360 |
88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77372031 |
89 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.77195015 |
90 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.77039474 |
91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.76707561 |
92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.76438392 |
93 | Salmonella infection_Homo sapiens_hsa05132 | 0.75954339 |
94 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75477147 |
95 | Adherens junction_Homo sapiens_hsa04520 | 0.75263480 |
96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75193044 |
97 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74091341 |
98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73820214 |
99 | Prion diseases_Homo sapiens_hsa05020 | 0.73580927 |
100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.72857333 |
101 | Phagosome_Homo sapiens_hsa04145 | 0.72795239 |
102 | Gap junction_Homo sapiens_hsa04540 | 0.72446352 |
103 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71785018 |
104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.71666908 |
105 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.71443951 |
106 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70218280 |
107 | Influenza A_Homo sapiens_hsa05164 | 0.69685614 |
108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68405540 |
109 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68099172 |
110 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67956559 |
111 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.67700698 |
112 | Melanogenesis_Homo sapiens_hsa04916 | 0.67281623 |
113 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.67132429 |
114 | Endocytosis_Homo sapiens_hsa04144 | 0.66123713 |
115 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66123545 |
116 | Insulin resistance_Homo sapiens_hsa04931 | 0.66070492 |
117 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66003100 |
118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65978671 |
119 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.65923843 |
120 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65502202 |
121 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63817138 |
122 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.63365059 |
123 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.63255280 |
124 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63029356 |
125 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60991912 |
126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59927382 |
127 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.58899541 |
128 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.58664978 |